JELD-WEN (JELD) Q4 2025 earnings review
Survival Mode: Leverage Explodes to 8.6x Amid Earnings Collapse
JELD-WEN's Q4 report signals a company in deep distress. While revenue fell 10.5% to $802M, the real damage was further down the P&L: Adjusted EBITDA collapsed 63% to just $14.8M, resulting in a razor-thin 1.8% margin. The combination of shrinking earnings and sticky debt caused Net Debt Leverage to skyrocket from 3.8x a year ago to a critical 8.6x. Management characterized results as at the 'high end of expectations,' but the FY26 guidance forecasts another year of revenue decline and flat-to-weak earnings, offering no immediate path out of the hole.
🐂 Bull Case
Unlike North America, the Europe segment grew revenue 9.4% in Q4 (aided by FX) and price realization was positive (+2%). Strategic review of this segment could unlock value or reduce debt.
Management cites lower SG&A and 'favorable productivity' as partial offsets in Q4. With $150M in savings targeted for 2025/26, the company is aggressively rightsizing the cost structure.
🐻 Bear Case
Net Debt Leverage ballooned to 8.6x (up from 3.8x in FY24) and 7.4x in Q3. With FY26 operating cash flow guided to a meager $40M, the company has almost no room for error or further deterioration.
The core market is imploding. North America revenue fell 18.4% and EBITDA collapsed 68%. Volume/mix was down 12%, signaling major market share losses or demand evaporation.
⚖️ Verdict: 🔴🔴
Sell. The leverage ratio of 8.6x is alarming and overshadows operational details. With revenue still shrinking in FY26 guidance and cash flow negligible ($40M OCF), the risk/reward is heavily skewed to the downside.
Key Themes
Leverage Crisis: 8.6x Ratio
The most critical metric in this report is the Net Debt Leverage ratio, which surged to 8.6x from 3.8x a year ago. This was driven by the denominator (EBITDA) evaporating rather than debt increasing. This level is typically unsustainable for cyclical industrial companies and puts equity holders at significant risk.
North America Segment Collapse
North America is the core problem. Q4 Revenue dropped 18.4% to $522M, but Adjusted EBITDA crashed 68% to just $13.6M. The segment margin compressed to ~2.6%. Drivers include a 12% volume/mix decline and negative price/cost. The loss of the 'Midwest retailer' business mentioned in prior quarters continues to haunt results.
Asset Valuation Write-downs
Management recorded a massive $334.6M non-cash goodwill impairment in 2025, admitting that previous acquisitions in North America and Europe are worth significantly less than carried. This effectively wipes out equity value on the balance sheet and confirms the structural deterioration of the business.
Negative Price/Cost Dynamics
For the first time in recent history, price/cost has turned into a distinct headwind (-270bps margin impact in Q4 combination with volume). While Europe saw +2% price realization, the consolidated picture shows the company lacks pricing power to offset inflation and inefficiencies in a down market.
Europe as the 'Stable' Segment
Europe outperformed North America significantly. Revenue grew 9.4% (though mostly FX driven, Core +1%). More importantly, while EBITDA fell 30%, the decline was far less severe than North America's 68% drop. Management noted improved productivity in the region, potentially positioning it for a sale to pay down debt.
Other KPIs
Cash burn accelerated. The company consumed $140.8M in cash for the year (excluding divestiture proceeds), compared to a use of $67.5M in FY24. Operating cash flow turned negative ($4.9M), failing to cover $135.9M in CapEx.
Decelerating. Core revenues fell 8%, driven entirely by an 8% decline in Volume/Mix. This excludes the impact of the Towanda divestiture (-5%) and FX benefits (+3%). Demand remains weak with no signs of a pivot.
Liquidity is tight but managed. Cash dropped from $150.3M a year ago. Management has not drawn on the revolver yet (per Q2 call), but with negative free cash flow, liquidity monitoring is essential.
Guidance
Decelerating. The midpoint ($3.025B) implies a ~6% decline from FY25's $3.21B. This confirms management does not expect a volume recovery in 2026.
Stable/Low. The midpoint ($125M) is roughly flat vs FY25 ($120M). Given the revenue decline, this implies slight margin expansion from cost cuts, but remains ~55% below FY24 levels ($275M).
Reversing to positive. A slight improvement from FY25's negative $4.9M, but critically low for a company with >$1B in debt. It likely barely covers maintenance CapEx.
Continuing trend. Management explicitly guides for organic contraction, stripping away any hope of a near-term cyclical rebound.
Key Questions
Covenant Breach Risk
With Net Debt Leverage at 8.6x and EBITDA guided flat for 2026, how close is the company to breaching any debt covenants, and what waivers might be required?
Cash Burn Runway
Guidance suggests only $40M in operating cash flow for 2026. If CapEx remains near FY25 levels ($136M), this implies another year of ~$100M cash burn. How will this be funded without increasing leverage further?
North America Margin Floor
North America EBITDA margin compressed to ~2.6% in Q4. Is this the bottom, or could operational deleverage turn this segment unprofitable in H1 2026?